Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy.
Thomas GastinneAmandine Le BourgeoisMarianne Coste-BurelThierry GuillaumePierre PeterlinAlice GarnierBerthe-Marie ImbertThomas DrumelBeatrice MaheViviane DubruilleNicolas BlinAnne LokCyrille TouzeauBenoît TessoulinMaxime JullienSophie VanthygemMarie Christine BenePhillipe MoreauSteven Le GouillPatrice ChevallierPublished in: British journal of haematology (2021)